ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis
نویسندگان
چکیده
منابع مشابه
ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis
OBJECTIVE This study aims to investigate cellular immunity and clinical efficacy of ShenQi FuZheng Injection (SFI) in the associated chemotherapy of colorectal cancer (CRC). METHODS PubMed, Cochrane Library, EMBASE, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Full-text Database (VIP), WanFang Database and Chinese Biomedical Literature Database (CBM) searches we...
متن کاملShenqi Fuzheng Injection Combined with Chemotherapy for Breast Cancer: A Meta-Analysis of Randomized Controlled Trials
Purpose. To evaluate the therapeutic effectiveness and safety of shenqi fuzheng injection (SFI) in the associated chemotherapy of breast cancer. Methods. 1247 subjects were included in this study for meta-analysis with RevMan 5.3. Results. The clinical curative effective rate (OR = 2.03, 95% Cl [1.44, 2.86], P < 0.0001), grades of KPS (OR = 4.11, 95% Cl [2.74, 6.16], P < 0.00001), CD3(+) cells ...
متن کاملImmunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis
Background. Immunosuppression is a well-recognised complication of chemotherapy in cancer patients. We assemble the clinical evidence that SQI, an adjuvant drug for lung cancer and gastric cancer which was widely prescribed in China, interventions could increase objective tumour response and regulate immunity in cancer patients undergoing chemotherapy. Methods. We undertook a systemic review of...
متن کامل[Clinical study on treatment of malignant neoplasms with Shenqi Fuzheng Injection and chemotherapy].
1 .1 纳入标准 (1)年龄 < 70 岁;(2)Karnofsky 活 动状况(Karnofs ky performance status, K PS)评分 > 60; (3)预计生存期 > 6 个月; (4)无化疗禁忌 症 ;(5)知情同意,依从性好,能连续完成 2 个疗程 的化疗。 1 .2 一般资料 2002 年 12 月~2004 年 5 月在我 院住院治疗且符合纳入标准的病理诊断明确的恶性 肿瘤患者,共 86 例,其中男 46 例,女 40 例;年龄 26~69 岁,平均 53 岁;其中肺癌 26 例, 大肠癌 22 例,鼻咽癌 16 例,乳腺癌 12 例,卵巢癌 6 例,恶 性淋巴瘤 4 例。 1 .3 病例分组 采用随机交叉试验设计,86 例患 者随机分为 A、B 两组。A 组 43 例,第 1 周期(对照 周期)给予化疗 1 个疗程,间歇 3~4 周,第 2 周期...
متن کاملZhenqi Fuzheng combined with chemotherapy for advanced stage lung cancer: a meta analysis
Purpose: To evaluate the outcomes (1 year survival rate, the therapeutic effectiveness and safety) of Zhenqi Fuzheng (ZQFZ) plus chemotherapy compared with chemotherapy alone and clarify its current role for stage II or IV of lung cancer. Methods: Eight studies included 450 patients were analyzed with Revman5.2. Fix models were used to evaluate the outcomes of these studies. Results: Patients r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: PLOS ONE
سال: 2017
ISSN: 1932-6203
DOI: 10.1371/journal.pone.0185254